ArticleContemporary clinical trials2024

Intermittent fasting for systemic triglyceride metabolic reprogramming (IFAST): Design and methods of a prospective, randomized, controlled trial.

Jacob A Quaytman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.